Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 1'-[6-[5-(Pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl]-5-(trifluoromethyl)spiro[3,4-dihydrochromene-2,4'-piperidine] | IC50 | 0.03 [1], 0.06 [2], 0.8 [3] | |
| MK-8245 | IC50 | 1.0 [1], 5.0 [2], 1066.0 [3], 1070.0 [4] | |
| N-(2-Hydroxy-2-(pyridin-3-yl)ethyl)-6-(4-(2-methylbenzoyl)piperidin-1-yl)pyridazine-3-carboxamide | IC50 | 28.0 [1], 43.0 [2] | |
| N-[5-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-1,3-thiazol-2-yl]-3-(2-hydroxyethoxy)-4-methoxybenzamide | IC50 | 0.2 [1], 0.3 [2], 26.0 [3] | |
| N-[(2R)-2-Hydroxy-2-phenylethyl]-6-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]pyridazine-3-carboxamide | IC50 | 15.0 [1], 25.0 [2], 71.0 [3] | |
MLA | "Quest Database™ Acyl-CoA desaturase Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 20 Dec. 2025, https://www.aatbio.com/data-sets/acyl-coa-desaturase-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 20). Quest Database™ Acyl-CoA desaturase Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/acyl-coa-desaturase-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |